| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |